🧬 BDNF Extraction Viewer

Извлечено: 997 / 997 (100.0%) Средняя confidence: 0.13
← Назад к списку

Clozapine-induced human microglial exosomes impair neurites and cognition.

PMID: 42019825 · DOI: 10.1016/j.bbi.2026.106776 · Brain, behavior, and immunity, 2026 · Kyle Hewitt, Adam Thomas, Peng Zheng, Nathan Nagaratnam, Xu-Feng Huang
📄 Abstract

Clozapine is the most effective treatment for treatment-resistant schizophrenia but has been linked to cognitive impairment and brain volume reductions. The potential mechanisms underlying these effects remain unclear. Microglial exosomes, which carry microRNAs (miRNAs) and other cargo, act as immune-neuron communication vectors capable of modulating neuronal function and cognition. We compared cognitive performance and inflammatory markers across clozapine-treated individuals, haloperidol-treated individuals, and healthy controls. Human microglial cells were treated with clozapine and assessed for phenotypic changes and exosome production. Exosomes from control and clozapine-treated microglia were applied to neuroblastoma cells and primary murine cortical neurons to assess neurite outgrowth and brain-derived neurotrophic factor (BDNF) expression. C. elegans were exposed to exosomes and evaluated for lifespan, healthspan markers, and cognitive function via olfactory associative learning assays. Exosomal miRNA cargo was characterized by small RNA sequencing. Clozapine-treated individuals exhibited elevated systemic inflammatory markers and lower cognitive performance compared with healthy controls. Clozapine altered microglial morphology, reduced proliferation and migration, and significantly increased exosome production. Small RNA sequencing identified six dysregulated miRNAs in clozapine-induced microglial exosomes, including upregulation of miR-34a-5p. Exposure of neurons to clozapine-induced exosomes reduced neurite length, branch points, and BDNF expression. In C. elegans, clozapine-induced exosomes reduced lifespan and severely impaired learning and short-term memory. These findings identify a neuroimmune exosomal pathway through which clozapine-exposed microglia can impair neuronal structure and cognition, associated with dysregulated miRNA cargo. This work provides a framework linking microglial immune signalling, extracellular vesicle biology, and cognitive vulnerability during clozapine exposure.

Confidence: 0.26 · 11 полей извлечено
Идентификация (6 полей)
Механизм действия (21 полей)
Mechanism
Clozapine alters microglial phenotype, increasing exosome production with dysregulated miRNA cargo (e.g., miR-34a-5p upregulation), which impairs neuronal structure and cognition.
0.90
Mutations (obesity/lean)
0.00
Activity (obesity)
0.00
Activity temporal
0.00
Energy balance
0.00
Appetite
0.00
Fat metabolism
0.00
Lipolysis
0.00
Thermogenesis
0.00
Muscle metabolism
0.00
Inflammation
Clozapine-treated individuals exhibited elevated systemic inflammatory markers; clozapine altered microglial morphology and increased exosome production.
0.90
Glucose metabolism
0.00
AA metabolism
0.00
Hormonal pathways
0.00
Cell death
0.00
Adipocyte fibrosis
0.00
Upstream (biochem)
0.00
Upstream (physiol)
0.00
Downstream (biochem)
miR-34a-5p upregulation in exosomes; reduced BDNF expression in neurons.
0.90
Downstream (physiol)
Reduced neurite outgrowth, impaired learning and memory, reduced lifespan in C. elegans.
0.90
PTMs
0.00
Экспрессия (8 полей)
Tissue expression
0.00
In vitro
Human microglial cells, neuroblastoma cells, primary murine cortical neurons
0.95
In vivo
Clozapine-treated individuals, haloperidol-treated individuals, healthy controls
0.90
In silico
0.00
Genetic association
0.00
Ex vivo
0.00
Animal model
C. elegans
0.95
Diet/model
0.00
Клиника (11 полей)
Drug
clozapine
1.00
Indication
treatment-resistant schizophrenia
1.00
Patient subgroups
0.00
Safety concerns
cognitive impairment and brain volume reductions
0.90
Off-target
0.00
Trial stage
0.00
Pharma competitors
0.00
AE severity
0.00
MOA weight loss
0.00
Endpoints
0.00
Approved
True
0.90